An integrated molecular risk score early in life for subsequent childhood asthma risk
Andreas Böck,Kathrin Urner,Jana Kristin Eckert,Michael Salvermoser,Kristina Laubhahn,Sonja Kunze,Jörg Kumbrink,Marc P. Hoeppner,Kathrin Kalkbrenner,Simone Kreimeier,Kirsten Beyer,Eckard Hamelmann,Michael Kabesch,Martin Depner,Gesine Hansen,Josef Riedler,Marjut Roponen,Elisabeth Schmausser‐Hechfellner,Cindy Barnig,Amandine Divaret‐Chauveau,Anne M. Karvonen,Juha Pekkanen,Remo Frei,Caroline Roduit,Roger Lauener,Bianca Schaub,CHAMP study group; PASTURE study group
DOI: https://doi.org/10.1111/cea.14475
2024-04-02
Clinical & Experimental Allergy
Abstract:For early prediction of childhood asthma, an integrated risk score combining established risk‐factors with genome‐wide molecular markers (genotype, DNA methylation, mRNA expression) at birth was defined, complemented by subsequent clinical symptoms/diagnoses (wheeze, atopic dermatitis, food allergy). While epidemiological predictors have moderate predictive power, molecular markers from birth improve prediction to a modest extent. Including allergic symptoms/diagnoses significantly increased predictive efficiency. Background Numerous children present with early wheeze symptoms, yet solely a subgroup develops childhood asthma. Early identification of children at risk is key for clinical monitoring, timely patient‐tailored treatment, and preventing chronic, severe sequelae. For early prediction of childhood asthma, we aimed to define an integrated risk score combining established risk factors with genome‐wide molecular markers at birth, complemented by subsequent clinical symptoms/diagnoses (wheezing, atopic dermatitis, food allergy). Methods Three longitudinal birth cohorts (PAULINA/PAULCHEN, n = 190 + 93 = 283, PASTURE, n = 1133) were used to predict childhood asthma (age 5–11) including epidemiological characteristics and molecular markers: genotype, DNA methylation and mRNA expression (RNASeq/NanoString). Apparent (ap) and optimism‐corrected (oc) performance (AUC/R2) was assessed leveraging evidence from independent studies (Naïve‐Bayes approach) combined with high‐dimensional logistic regression models (LASSO). Results Asthma prediction with epidemiological characteristics at birth (maternal asthma, sex, farm environment) yielded an ocAUC = 0.65. Inclusion of molecular markers as predictors resulted in an improvement in apparent prediction performance, however, for optimism‐corrected performance only a moderate increase was observed (upto ocAUC = 0.68). The greatest discriminate power was reached by adding the first symptoms/diagnosis (up to ocAUC = 0.76; increase of 0.08, p = .002). Longitudinal analysis of selected mRNA expression in PASTURE (cord blood, 1, 4.5, 6 years) showed that expression at age six had the strongest association with asthma and correlation of genes getting larger over time (r = .59, p
immunology,allergy